Zhanfang Kang

6PUBLICATIONS
16CO-AUTHORS
Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Pacific Peoples sport and physical activityGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 25, 2026
4-HNE induces cell death through the VCP-related ubiquitination pathway in diabetic cardiomyopathy and the protective effect of metformin.

|Mar 24, 2026
Sex-specific KDM6A-HNF4A-CREBH network controls lipoprotein cholesterol metabolism and atherosclerosis via epigenetic reprograming of hepatocytes.

Lin Chen, Zhanfang Kang, Jennifer Härdfeldt

|Mar 20, 2026
Discovery of a Potent RXRγ Degrader WCF-598 for the Treatment of Castration-Resistant Prostate Cancer.

Chaofan Wang, Jieying Lin, Junping Pei

|Feb 23, 2023
DT-010 Exerts Cardioprotective Effects by Regulating the Crosstalk between the AMPK/PGC-1α Pathway and ERp57.

Xiaojing Zhang, Ximin Wu, Huihui Hu

|Sep 30, 2022
Thymoquinone induces apoptosis in temozolomide-resistant glioblastoma cells via the p38 mitogen-activated protein kinase signaling pathway.

Ai Mai, Shu-Wen Ye, Jia-Yu Tu

|May 29, 2019
Hyperglycemia induces NF-κB activation and MCP-1 expression via downregulating GLP-1R expression in rat mesangial cells: inhibition by metformin.

Zhanfang Kang, Jianwen Zeng, Tian Zhang

Pageof 1

Frequent Collaborators

1 joint publications

Ai Mai

1 joint publications

Shu-Wen Ye

1 joint publications

Jun Gao

1 joint publications

Wei-Jen Ting